
Mike Thompson/LinkedIn
Nov 21, 2024, 16:11
Mike Thompson: Myeloma/Plasma Cell Dyscrasia – Top Abstract Highlights from ASH24
Mike Thompson, Vice President of Clinical Partnerships at Tempus AI, shared a post on X:
“Myeloma/Plasma Cell Dyscrasia ~ ASH24Top10 (or so) Multiple Myeloma ASH24 by Mike Thompson
*DRAFT* Table Update: Nov 20, 2024″

-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 1, 2025, 12:48
Apr 1, 2025, 12:16
Apr 1, 2025, 12:13
Apr 1, 2025, 12:07
Apr 1, 2025, 11:53
Apr 1, 2025, 11:51